This Revision Application proposal seeks to break new ground in regard to the scope and aims of the parent RO1, which was awarded for 5 years beginning 03/01/08. Consistent with the goals of the Recovery Act and notice NOT-OD-09- 058, we plan to systematically collect and analyze olfactory epithelial biopsy tissue as well as perform detailed peripheral and central electrophysiological studies of the olfactory system in schizophrenia patients and healthy controls. Olfactory epithelium is unique in that it constitutes the sole source of regenerating neural cells that can be obtained from a living human. That is, the location of olfactory receptor neurons in the nasal epithelium allows noninvasive access to these neurons in living subjects. This offers a unique opportunity to directly assess neuronal integrity in vivo in patients. Primary cultures derived from human olfactory epithelial biopsies can subsequently be utilized to study neurobiological characteristics of individuals under different conditions and disease states. The collection of olfactory biopsy tissue will allow for further characterization of basal cells in OE in terms of their ultrastructural features as well as gene expression profiling to better define the role of each cell type in neurogenesis. New methodologies will be employed to examine peripheral components of olfactory sensory processing, i.e., olfactory event-related potentials (OERPs), as well as more traditional scalp recordings of the olfactory- evoked potential. We will study 30 schizophrenia patients and 30 unrelated healthy controls. Results from the in vivo electrophysiological studies will be integrated with the results of the cellular and molecular studies that use ORN tissue biopsies obtained from the same subjects. Our working model is that olfactory deficits reflect genetically-mediated abnormalities in neuron-to-neuron connectivity, arising from neurodevelopmentally disturbed processes of neurogenesis and synapse formation. Penn Medicine contributes substantially to the local economy. In 2008, Penn Medicine created 37,000 jobs and $5.4 billion in regional economic activity, with the area's highly trained workforce producing more than 24,600 applications for just 840 open Penn staff research positions. The current proposal will create or retain 2.5 jobs.

Public Health Relevance

Schizophrenia is currently thought to be a complex genetic disorder, with altered neuronal development, perhaps very early in life, important in determining vulnerability. Neurogenesis and neurodevelopment occur in the adult olfactory epithelium (OE), and the collection and study of olfactory biopsy tissue may provide insights into the neuro- biological basis of altered neurodevelopment in this disorder. We plan to collect and analyze OE biopsy tissue as well as perform detailed peripheral and central electrophysiological studies of the olfactory system in schizophrenia patients and healthy controls. Penn Medicine contributes substantially to the local economy. In 2008, Penn Medicine created 37,000 jobs and $5.4 billion in regional economic activity, with the area's highly trained workforce producing more than 24,600 applications for just 840 open Penn staff research positions. The current proposal will create or retain 2.5 jobs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH063381-07S1
Application #
7822568
Study Section
Special Emphasis Panel (ZRG1-BDCN-C (96))
Program Officer
Meinecke, Douglas L
Project Start
2009-09-30
Project End
2012-08-31
Budget Start
2009-09-30
Budget End
2012-08-31
Support Year
7
Fiscal Year
2009
Total Cost
$338,035
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kamath, Vidyulata; Turetsky, Bruce I; Calkins, Monica E et al. (2014) Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J Biol Psychiatry 15:209-18
Moberg, Paul J; Kamath, Vidyulata; Marchetto, Dana M et al. (2014) Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull 40:50-9
Kamath, Vidyulata; Moberg, Paul J; Kohler, Christian G et al. (2013) Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull 39:59-67
Kamath, Vidyulata; Turetsky, Bruce I; Seligman, Sarah C et al. (2013) The influence of semantic processing on odor identification ability in schizophrenia. Arch Clin Neuropsychol 28:254-61
Dalton, Pamela; Doty, Richard L; Murphy, Claire et al. (2013) Olfactory assessment using the NIH Toolbox. Neurology 80:S32-6
Kamath, Vidyulata; Turetsky, Bruce I; Calkins, Monica E et al. (2013) The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth. J Psychiatr Res 47:1636-41
Kamath, Vidyulata; Moberg, Paul J; Gur, Raquel E et al. (2012) Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia. Behav Neurosci 126:209-215
Kamath, Vidyulata; Moberg, Paul J; Calkins, Monica E et al. (2012) An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis. Schizophr Res 138:280-4
Brewer, Warrick J; Lin, Ashleigh; Moberg, Paul J et al. (2012) Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker. Psychiatry Res 199:8-11
Moberg, Paul J; Li, Mingyao; Kanes, Stephen J et al. (2012) Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q. Psychiatr Genet 22:286-9

Showing the most recent 10 out of 29 publications